EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

HLA ‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones

Paola Nicoletti, M Isabel Lucena, Raul J Andrade iD, Samreen Zafer, Einar S Bjornsson iD, Pär Hallberg, Dominique Larrey, Mariam Molokhia, Mia Wadelius, Guruprasad P Aithal, Ann K Daly iD

Liver International · 2026-06 · 46 (6)

DOI: 10.1111/liv.70699 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Liver International, online erschienen am 15.05.2026. Verfasst von Paola Nicoletti und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, HLA-DQ alpha-Chains, HLA-B Antigens, Fluoroquinolones. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Fluoroquinolone exposure can give rise to drug‐induced liver injury. Genetic risk factors for this form of liver injury are poorly understood but some evidence suggests that HLA genes contribute. This study aimed to characterise HLA risk factors for fluoroquinolone‐induced liver injury in a European population.

Methods

From the previously described iDILIC cohort, 22 cases of fluoroquinolone‐induced liver injury were identified, with most cases ( n = 13) related to ciprofloxacin. Liver injury cases due to other drugs ( n = 458), also from iDILIC, served as controls. HLA genotypes were imputed from genome‐wide association analysis data using SNPtoHLA. Frequency differences between cases and controls for HLA alleles, HLA amino acids and HLA families were assessed by applying a logistic regression model.

Results

HLA‐significant associations were detected for HLA class I and II alleles with individual allelic associations detected for HLA‐B*44:03 , HLA‐A*29:02 , HLA‐C*16:01, HLA‐DQA1*03:01 and several HLA‐DRB1 alleles. Combined HLA‐B*44 alleles were associated with DILI with an odds ratio of 5.33 [95% confidence interval 2.45–11.61; p = 2.5 × 10 −5 ]. Serine at position‐167 in HLA‐B, specific to B*44:02, B*44:03 and B*45:01 , was associated with a significantly increased risk of liver injury ( p = 4.7 × 10 −6 ), but no other HLA‐B amino acids were significant. The B*44 association was also significant among ciprofloxacin cases only.

Conclusions

A novel HLA‐B*44 association with fluoroquinolone‐induced liver injury has been identified and a previously reported but weaker association with HLA‐DQA1*03:01 confirmed. The B*44 findings suggest a mechanism involving inappropriate recognition of drug‐modified self peptides by serine‐167 in pocket A of the HLA‐B protein.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chemical and Drug Induced Liver InjuryHLA-DQ alpha-ChainsHLA-B AntigensFluoroquinolonesAnti-Bacterial AgentsHumansFemaleRisk FactorsMaleMiddle AgedGenetic Predisposition to DiseaseAllelesAgedLogistic ModelsAdultCiprofloxacinCase-Control StudiesGene FrequencyGenome-Wide Association Study

Stichwörter der Autor:innen

HLA alleleciprofloxacindrug‐induced liver injuryfluoroquinolone

Substanzen

HLA-DQ alpha-ChainsHLA-DQA1 antigenHLA-B AntigensFluoroquinolonesAnti-Bacterial AgentsCiprofloxacin

Autor:innen und Institutionen

  • Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, USA.
  • UGC Digestivo y Servicio de Farmacología Clínica, Instituto de Investigación Biomédica de Málaga-Plataforma Bionand (IBIMA Plataforma Bionand), Hospital Universitario Virgen de la Victoria, Universidad de Málaga, Málaga…
  • Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Madrid, Spain.
  • Division of Gastroenterology and Hepatology, Department of Internal Medicine, The National University Hospital of Iceland, Reykjavik, Iceland.
  • Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  • Department of Medical Sciences, Clinical Pharmacogenomics, Uppsala University, Uppsala, Sweden.

ORCID-Profile: Raul J Andrade, Einar S Bjornsson, Ann K Daly

Zitieren

APA

Nicoletti, P., Lucena, M. I., Andrade, R. J., Zafer, S., Bjornsson, E. S., Hallberg, P., Larrey, D., Molokhia, M., Wadelius, M., Aithal, G. P., & Daly, A. K. (2026). HLA ‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones. Liver International, 46(6). https://doi.org/10.1111/liv.70699

Vancouver

Nicoletti P, Lucena MI, Andrade RJ, Zafer S, Bjornsson ES, Hallberg P, et al. HLA ‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones. Liver International. 2026;46(6). doi:10.1111/liv.70699

BibTeX
@article{Nicoletti2026,
  author = {Nicoletti, Paola and Lucena, M Isabel and Andrade, Raul J and Zafer, Samreen and Bjornsson, Einar S and Hallberg, Pär and Larrey, Dominique and Molokhia, Mariam and Wadelius, Mia and Aithal, Guruprasad P and Daly, Ann K},
  title = {HLA ‐B*44 Alleles and HLA‐DQA1*03:01 as Genetic Risk Factors for Drug‐Induced Liver Injury due to Fluoroquinolones},
  journal = {Liver International},
  year = {2026},
  volume = {46},
  number = {6},
  doi = {10.1111/liv.70699}
}
Kostenlos starten →